Answers are grounded in this paper and cite their sources.
These findings reiterate molecular heterogeneity of HNSCC and advantages of scRNA-seq in pinpointing cellular diversities in complex cancer ecosystems. Our HNSCC iCMS regime might facilitate accurate patient stratification and individualized precise treatment.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: